Genomic Valley Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 0.09 | 0.09 | 0.26 |
| Operating Expense | 0.09 | 0.06 | 0.26 |
| Net Profit | TBA | 0.02 | -0.08 |
| Net Profit Margin | TBA | 22.22 | -30.77 |
| Earning Per Share | 0.01 | 0.08 | -0.27 |
| EBIDTA | TBA | 0.02 | 0.01 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 0.09 |
| Operating Expense | 0.09 |
| Net Profit | TBA |
| Net Profit Margin | TBA |
| Earning Per Share | 0.01 |
| EBIDTA | TBA |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 0.17 | 2.72 | 0.07 |
| Operating Expenses Annual | 0.15 | 1.84 | 0.45 |
| Operating Profit Annual | 0.02 | 0.66 | 0.13 |
| Interest Annual | TBA | TBA | 0.04 |
| Depreciation | 0.00 | 0.01 | 0.08 |
| Net Profit Annual | 0.02 | 0.65 | -0.01 |
| Tax Annual | -0.00 | 0.00 | 0.01 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 0.17 |
| Operating Expenses Annual | 0.15 |
| Operating Profit Annual | 0.02 |
| Interest Annual | TBA |
| Depreciation | 0.00 |
| Net Profit Annual | 0.02 |
| Tax Annual | -0.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.04 | TBA | 0.01 |
| Cash Flow from Operations | -0.02 | -0.78 | -2.13 |
| Cash Flow from Investing | -0.02 | 1.52 | 3.67 |
| Cash Flow from Financing | TBA | -0.70 | -1.55 |
| Cash Flow at the End | 0.01 | 0.04 | TBA |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.04 |
| Cash Flow from Operations | -0.02 |
| Cash Flow from Investing | -0.02 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 11.76 | 33.82 | -428.57 |
| PBIT Margin (%) | 11.76 | 33.46 | -542.86 |
| PBT Margin (%) | 11.76 | 33.46 | 13,028.57 |
| Net PROFIT Margin (%) | 11.76 | 23.90 | -14.29 |
| Return On Networth / Equity (%) | 0.57 | 28.48 | TBA |
| Return On Networth /Employed (%) | 0.57 | 25.67 | TBA |
| Return On Assets (%) | 0.59 | 18.40 | -0.14 |
| Total Debt / Equity (X) | TBA | TBA | 0.21 |
| Asset Turnover Ratio (%) | 0.05 | 0.77 | 0.01 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 11.76 |
| PBIT Margin (%) | 11.76 |
| PBT Margin (%) | 11.76 |
| Net PROFIT Margin (%) | 11.76 |
| Return On Networth / Equity (%) | 0.57 |
| Return On Networth /Employed (%) | 0.57 |
| Return On Assets (%) | 0.59 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.00 | 0.00 | 1.75 |
| Total Current Assets Annual | 2.91 | 2.58 | 1.14 |
| Non Current Assets Annual | 1.42 | 1.84 | 2.66 |
| Total Shareholders Funds Annual | 3.54 | 3.53 | 2.88 |
| Total Assets Annual | 4.33 | 4.42 | 3.80 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.00 |
| Total Current Assets Annual | 2.91 |
| Non Current Assets Annual | 1.42 |
| Total Shareholders Funds Annual | 3.54 |
| Total Assets Annual | 4.33 |
No Data Availabe
